This inventor holds 1 USPTO granted patent, plus 2 CIPO patents. Top assignees: Japanese Foundation for Cancer Research, Kabushiki Kaisha Yakult Honsha, Riken Corporation. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2022
Title: Masayuki Okue: Innovator in Pharmaceutical Chemistry
Introduction
Masayuki Okue is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patent work. His research focuses on compounds that have potential therapeutic applications.
Latest Patents
Masayuki Okue holds a patent for a compound or pharmaceutically acceptable salt thereof. This patent includes 2-(piperidin-1-yl)pyrimidin-4(3H)-ones or their pharmaceutically acceptable salts. These compounds are characterized by having various spirocyclic structures, which are represented by a specific general formula. This innovation could lead to advancements in drug development and treatment options.
Career Highlights
Throughout his career, Masayuki Okue has worked with prominent organizations such as Riken Corporation and the Japanese Foundation for Cancer Research. His work in these institutions has allowed him to contribute to significant research and development projects in the pharmaceutical sector.
Collaborations
Masayuki Okue has collaborated with esteemed colleagues, including Minoru Yoshida and Hiroyuki Seimiya. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Masayuki Okue's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science and drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile